SCHEMBL11148292

SCHEMBL11148292

CN1C(=O)CSC1=NC(=O)Nc1c(Cl)cccc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ GRM5 P41594 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HPGD P15428 1/20 0.39
▸ P2RX7 Q99572 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PTGS2 P35354 1/20 0.37
▸ PDK1 Q15118 1/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ PDK3 Q15120 1/20 0.36
▸ PDK4 Q16654 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ GBA1 P04062 1/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11150708 0.93 MEN1 (0.43) GRM5MEN1KMT2AP2RX7ALDH1A1
SCHEMBL11155555 0.90 GRM5 (0.46) L3MBTL1GRM5MEN1KMT2AALDH1A1
SCHEMBL11155554 0.90 GRM5 (0.46) L3MBTL1GRM5MEN1KMT2AALDH1A1
SCHEMBL11146126 0.89 RIPK1 (0.40) GRM5MEN1KMT2AHPGDP2RX7
SCHEMBL11147044 0.88 MEN1 (0.39) GRM5MEN1KMT2AP2RX7ALDH1A1
SCHEMBL11146311 0.87 GRM5 (0.42) L3MBTL1GRM5MEN1KMT2AALDH1A1
SCHEMBL11148675 0.86 L3MBTL1 (0.52) L3MBTL1KMT2AHPGDP2RX7ALDH1A1
SCHEMBL11144521 0.85 GRM5 (0.42) L3MBTL1GRM5MEN1KMT2AALDH1A1
SCHEMBL11141779 0.85 GRM5 (0.42) L3MBTL1GRM5MEN1KMT2AALDH1A1
SCHEMBL11145628 0.84 GRM5 (0.42) L3MBTL1GRM5MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4402964-A N-Aryl-N'-(3-methyl or ethyl-4-oxothiazolidinylidene)ureas useful for the treatment of epilepsy MCNEILAB, INC. (US) 1983-09-06 — — US disclosed
Send feedback